Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo

European Journal of Dermatology

Volumn 8, Issue 1, 1998, Pages 13-15

  Buc, Milan ^a   Fazekašová, Henrieta ^a   Čechová, Eva ^a   Hegyi, Eugen ^a   Kolibášová, Klaudia ^a   Ferenčík, Stanislav ^b  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Class II HLA alleles; Slovak population; Vitiligo

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; SLOVAKIA; VITILIGO;

ADULT; ALLELES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; POLYMERASE CHAIN REACTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SLOVAKIA; VITILIGO;

EID: 0031776428     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lorini R, Orecchia G, Martinetti M, Dugoujon JM, Cuccia M. Autoimmunity in vitiligo: relationship with HLA, Gm, and Km polymorphisms. Autoimmunity 1992; 11: 255-60.
2. Morris A, Kissinger RM, Naughton GM, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol 1988; 90: 783-9.
3. Song YH, Connor E, Li Y. The role of tyrosinase in autoimmune vitiligo. Lancet 1994; 344: 1049-50.
4. + T cell subsets and evidence for peripheral T cell activation. Int J Dermatol 1992; 31: 321-6.
5. Lerner AB. On the etiology of vitiligo and gray hair. Am J Med 1971; 51: 141-7.
6. Howitz L, Brodthagen H, Swartz M. Prevalence of vitiligo. Arch Dermatol 1977; 113: 47-52.
7. Stites DP, Terr TG, Parslow AI (eds). Basic and Clinical Immunology. Appleton and Lange 1994, East Norwalk, 870 p.
8. Lechler R (ed.). HLA and diseases. Academic Press 1994, London, Boston, San Diego, New York, Sydney, Tokyo, 186 p.
9. Buc M. The major histocompatibility complex in man. Folia Biol (Praha) 1995; 41: 119-22.
10. Bue M, Bušová B, Hegyi E, Kolibášová K. Vitiligo is asssociated with HLA-A2 and HLA-Dw7 in the Slovak population. Folia Biol (Praha) 1996; 42: 23-5.
11. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
12. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-34.
13. Hviid TVF, Madsen HO, Morling N. HLA-DPB1 typing with polymerase chain reaction and restriction length polymorphism technique in Danes. Tissue Antigens 1994; 40: 140-4.
14. Foley LM, Lowe NJ, Mishloff E, Tiwari JL. Association of HLA-DR4 with vitiligo. J Am Acad Dermatol 1983; 38: 39-40.
15. Poloy A, Tibor L, Kramer J, Anh-Tuan N, Kraszits E, Medgyessy I, Fust G, Stensky V, Farid NR. HLA-DR1 is associated with vitiligo. Immunol Letters 1991; 27: 59-62.
16. Finco O, Cuccia M, Martinetti M, Ruberto G, Orecchia G, Rabbiosi G. Age onset in vitiligo: relationship with HLA supratypes. Clin Genetics 1991; 39: 48-54.
17. Orecchia G, Perfetti L, Malagoli P, Borghini F, Kipervarg Y. Vitiligo is associated with a significant increase in HLA-A30, Cw6, and DQw3 and a decrease in C4Q0 in northern Italian patients. Dermatol 1992; 185: 123-7.
18. Venneker GT, de Waal LP, Westerhof WD, Amaros J, Schreuder GMTH, Asghar SS. HLA associations in vitiligo patients in the Dutch population. Disease Markers 1993; 11: 187-90.
19. WHO. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997; 49: 297-321.
20. Rich RR (ed.). Clinical Immunology. Principle and Practice. Mosby 1996. St. Louis, Baltimore, Boston, Carlsbad, Chicago, Naples, New York, Philadelphia, Portland, London, Madrid, Mexico City, Singapore, Tokyo, Toronto, Wiesbaden. 1052 p. (Vol. I), 2228 p. (vol. II).